Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-045524
Filing Date
2025-03-26
Accepted
2025-03-26 18:11:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5230
  Complete submission text file 0000950170-25-045524.txt   6844
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
KAKKIS EMIL D (Filed by) CIK: 0001248093 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 3 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 3 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-842-7250
QT IMAGING HOLDINGS, INC. (Subject) CIK: 0001844505 (see all company filings)

EIN.: 861728920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92895 | Film No.: 25774634
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)